EP Patent

EP3415139A1 — Administration of benzodiazepine

Assigned to Neurelis Inc · Expires 2018-12-19 · 7y expired

What this patent protects

The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.

USPTO Abstract

The invention relates to pharmaceutical compositions comprising one or more benzodiazepine drugs for nasal administration, methods for producing and for using such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
EP3415139A1
Jurisdiction
EP
Classification
—
Expires
2018-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Neurelis Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.